Tell me hypo and hyper natremia and kalemia in detail with proper understanding with photos medicine mbbs

Reading File

Finding Sources

Reading File

Finding Sources

Reading File

Loading Image

Reading File

Finding Sources

Reading File

Loading Image

Reading File

Finding Sources

Reading File

Finding Sources

Reading File

Finding Sources

Reading File

Loading Image

I have enough data to compile a comprehensive answer. Let me now write the complete detailed response.

Disorders of Sodium and Potassium: Complete MBBS Guide

PART 1: SODIUM DISORDERS

Normal Values

Parameter	Normal Range
Serum Na+	136-145 mmol/L
Plasma Osmolality	280-295 mOsm/kg
Urine Osmolality	50-1200 mOsm/kg

HYPONATREMIA (Na+ < 136 mmol/L)

Definition & Epidemiology

Hyponatremia is the most commonly encountered electrolyte disorder, with incidences as high as 15-30% in hospitalized patients. It is defined as plasma Na+ < 135-136 mmol/L and is a marker for worse outcomes - a serum sodium < 135 mmol/L is associated with ~45% relative increase in ICU admission rates.

Tietz Textbook of Laboratory Medicine, 7th Ed
Goldman-Cecil Medicine

Step 1: Classify by Plasma Osmolality

The first step is always to measure plasma osmolality. This divides hyponatremia into three types:

Algorithm for differential diagnosis of hyponatremia showing plasma osmolality pathways

Fig. Differential diagnosis of hyponatremia by plasma osmolality and volume status (Tietz Textbook of Laboratory Medicine)

A. Isotonic Hyponatremia (Pseudo-hyponatremia)

Plasma osmolality = NORMAL (280-295 mOsm/kg)
No true water excess; artifact of measurement
Causes: Hyperlipidemia, Hyperproteinemia (multiple myeloma, Waldenstrom's macroglobulinemia)
No treatment needed for the Na+ itself

B. Hypertonic Hyponatremia

Plasma osmolality = INCREASED (>295 mOsm/kg)
Another osmotically active solute draws water out of cells, diluting Na+
Causes: Hyperglycemia (for every 100 mg/dL rise in glucose above normal, Na+ drops ~1.6 mEq/L), Mannitol, Uremia

C. Hypotonic Hyponatremia (the true hyponatremia you must treat)

Plasma osmolality = DECREASED (<280 mOsm/kg)
Always reflects an underlying disorder with abnormal retention of body water

Step 2: Classify Hypotonic Hyponatremia by Volume Status

Volume Status	ECF	Mechanism	Key Causes
Hypovolemic	Low	Na+ loss > water loss	Diarrhea, vomiting, burns, sweating (extrarenal); diuretics, mineralocorticoid deficiency, salt-losing nephropathy (renal)
Euvolemic	Normal	Water retention with normal/low Na+	SIADH, hypothyroidism, hypoadrenalism, reset osmostat, excess water intake
Hypervolemic	High	Water excess with normal or elevated Na+	CHF, cirrhosis with ascites, nephrotic syndrome, renal failure

Key lab differentiator - Urine Na+:

Urine Na+ >20 mmol/L = renal losses (diuretics, SIADH, renal failure, mineralocorticoid deficiency)
Urine Na+ <10 mmol/L = extrarenal losses (CHF, cirrhosis, vomiting, diarrhea)

SIADH (Syndrome of Inappropriate ADH Secretion)

This is the most common cause of euvolemic hyponatremia and deserves special attention.

Diagnostic criteria:

Hypo-osmolar hyponatremia (plasma Osm <280)
Urine osmolality > plasma osmolality (inappropriately concentrated urine, usually >100 mOsm/kg)
Urine Na+ >20-40 mmol/L
Normal renal, adrenal, thyroid function
Patient is euvolemic

Causes of SIADH (mnemonic - SIADH itself):

CNS disorders: meningitis, SAH, head trauma, stroke
Pulmonary: pneumonia, TB, abscess, SCLC
Drugs: SSRIs, carbamazepine, cyclophosphamide, NSAIDs, morphine, oxytocin
Tumors: small cell lung cancer (ectopic ADH), pancreatic ca
Misc: pain, nausea, postoperative state

Clinical Features of Hyponatremia

Symptoms are primarily neurological due to osmotic water shift INTO brain cells (cerebral edema):

Plasma Na+ (mmol/L)	Symptoms
130-135	Often asymptomatic; nausea, malaise
125-130	Headache, lethargy, confusion
120-125	Generalized weakness, mental confusion
<120	Severe confusion, stupor, seizures
<105	Coma, respiratory arrest, death

Important: Symptoms develop faster with acute hyponatremia (hours-days) vs. chronic (>48 hrs). In chronic hyponatremia, the brain adapts by extruding osmolytes, so symptoms may be minimal even at Na+ <120.

Women between menarche and menopause are at greater risk for fatal cerebral edema from acute hyponatremia.

Osmotic Demyelination Syndrome (ODS) / Central Pontine Myelinolysis (CPM)

This is the most feared complication of overcorrecting hyponatremia too rapidly.

Mechanism: Rapid correction of chronic hyponatremia causes the brain (which has adapted by extruding osmolytes) to undergo sudden dehydration. This damages myelin sheaths - predominantly in the central pons.

Risk factors:

Severe chronic hyponatremia (Na+ <120, duration >48 hrs)
Alcoholism, malnutrition, liver transplantation (incidence 13-29% at autopsy), hypokalemia

Clinical picture (BIPHASIC):

Initial improvement with correction
2-3 days later: behavioral changes, cranial nerve palsies, progressive quadriplegia, "locked-in syndrome"

MRI: T2 hyperintense non-enhancing pontine and extrapontine lesions (may not appear for 2 weeks)

Prevention:

Correct Na+ by no more than 8-10 mEq/L per 24 hours (max 18 mEq/L per 48 hrs)
In high-risk patients: max 8 mEq/L per 24 hrs

Treatment of Hyponatremia

General principle: Rate of correction depends on duration and severity of symptoms

Scenario	Correction Strategy
Acute symptomatic (<48 hrs, seizures/coma)	3% hypertonic saline IV; raise Na+ by 1-2 mEq/L/hr until symptoms resolve (max ~5 mEq in first 1-2 hrs); then slow to <8-10 mEq/24hrs
Chronic symptomatic (mild-moderate)	Fluid restriction ± 3% saline; max 8-10 mEq/L/24 hrs
Hypovolemic	0.9% normal saline (corrects volume, allows ADH to suppress, kidneys excrete free water)
SIADH	Fluid restriction (800-1000 mL/day); vaptans (tolvaptan, conivaptan) if persistent
Hypervolemic (CHF, cirrhosis)	Fluid restriction, treat underlying cause, loop diuretics

Vaptans (V2 receptor antagonists): Tolvaptan, conivaptan - block ADH at V2 receptor in collecting duct, promote free water excretion (aquaresis) without sodium loss. Used in SIADH and hypervolemic hyponatremia.

HYPERNATREMIA (Na+ > 144-145 mmol/L)

Definition & Key Concept

Hypernatremia ALWAYS reflects hypertonicity - water deficit relative to sodium. It always means the body has too little water relative to its solute load. The primary defense is thirst - failure of this mechanism is almost always required for hypernatremia to persist.

Goldman-Cecil Medicine

Causes - Classified by Volume Status

Category	Mechanism	Examples
Hypovolemic	Water lost > Na+ lost	Diarrhea, vomiting, burns, sweating, loop diuretics, osmotic diuresis
Euvolemic (Near-normovolemic)	Pure water loss	Diabetes insipidus (central or nephrogenic), fever/insensible loss, inadequate water intake (adipsia/hypodipsia)
Hypervolemic	Excess Na+ gain	Hypertonic saline, sodium bicarbonate excess, hyperaldosteronism, Cushing's

Diabetes Insipidus (DI) - Key Cause of Hypernatremia

Feature	Central DI	Nephrogenic DI
Defect	ADH production/release (pituitary/hypothalamus)	Renal tubule unresponsive to ADH
Causes	Head trauma, neurosurgery, tumors, infiltrative (sarcoid, histio X), idiopathic	Lithium, demeclocycline, hypercalcemia, hypokalemia, CKD, genetic (V2R mutation)
Urine Osm after water deprivation	Low (<200); rises with DDAVP	Low (<200); NO rise with DDAVP
Treatment	DDAVP (desmopressin)	Treat cause; thiazide diuretics + low Na diet; NSAIDs; amiloride (lithium-induced)

Diagnosis: Urine osmolality <100-200 mOsm/kg + polyuria (>3 L/day) in the setting of hypernatremia strongly suggests DI

Clinical Features of Hypernatremia

Primary symptoms are neurological (due to water shifting OUT of brain cells - cell shrinkage):

Early: Thirst, restlessness, irritability
Moderate: Confusion, weakness, focal neurologic deficits, muscle twitching
Severe: Decreasing consciousness → seizures → coma
Brain cell shrinkage can rupture bridging veins → subdural hemorrhage

In patients with hypernatremia of sufficient duration, brain cells compensate by generating "idiogenic osmoles" (organic osmolytes), reducing clinical manifestations.

Treatment of Hypernatremia

Free Water Deficit Formula:

Water deficit = TBW × [(plasma Na+ / 140) - 1] TBW = 0.6 × lean body weight (men) or 0.5 × lean body weight (women)

Example: 70 kg man, Na+ = 160 mEq/L

TBW = 0.6 × 70 = 42 L
Water deficit = 42 × (160/140 - 1) = 42 × 0.143 = 6 L

Priority	Action
1. Hemodynamic instability	0.9% saline first to restore volume
2. Calculate water deficit	Use formula above
3. Choose replacement fluid	D5W (free water), 0.45% saline, or oral water
4. Rate of correction	Max 0.5-1 mEq/L/hour (max 10-12 mEq/L/day) to avoid cerebral edema from rapid rehydration
5. Treat underlying cause	Stop offending agents, treat DI, etc.

Warning: Correcting too fast (>0.7 mEq/L/hr) is dangerous and can lead to cerebral edema. The brain's accumulated idiogenic osmoles retain water rapidly when plasma osmolality drops.

National Kidney Foundation Primer on Kidney Diseases, 8th Ed

PART 2: POTASSIUM DISORDERS

Normal Values & Physiology

Parameter	Value
Normal serum K+	3.5-5.0 mEq/L
Intracellular K+	~140 mEq/L
Extracellular K+	~4 mEq/L
Total body K+	~3500 mEq (98% intracellular)

Key physiological point: 98% of body potassium is intracellular. The serum K+ level does NOT directly reflect total body K+ stores. Transcellular shifts can change serum K+ dramatically with no change in total body K+.

What moves K+ INTO cells (lowers serum K+):

Insulin
Beta-2 adrenergic stimulation (catecholamines)
Alkalosis
Thyroid hormone

What moves K+ OUT of cells (raises serum K+):

Acidosis (especially metabolic/hyperchloremic)
Insulin deficiency
Beta-blockade
Hypertonicity/hyperglycemia
Cell destruction

Medical Physiology (Boron & Boulpaep); Harrison's Principles of Internal Medicine 22E

HYPOKALEMIA (K+ < 3.5 mEq/L)

Causes

1. RENAL LOSSES (most common; urine K+ >20 mEq/L)

Category	Examples
Diuretics	Loop diuretics (furosemide), thiazides - most common cause
Mineralocorticoid excess	Primary hyperaldosteronism (Conn's), secondary aldosteronism, Cushing's
Renal tubular disorders	RTA type 1 & 2, Fanconi syndrome
Magnesium deficiency	Refractory hypokalemia - always check Mg2+
Drugs	Amphotericin B, aminoglycosides, cisplatin
Bartter and Gitelman syndromes	Genetic tubular disorders

2. GASTROINTESTINAL LOSSES (urine K+ <20 mEq/L)

Severe diarrhea (secretory diarrhea - high K+ content)
Vomiting (indirect - metabolic alkalosis drives renal K+ wasting + low Cl-)
Laxative abuse
Malabsorption, fistulas, ileostomy

3. POOR INTAKE

Starvation, alcoholism, anorexia
Pica (clay ingestion binds K+ in GI tract)
IV fluids without K+ replacement

4. TRANSCELLULAR SHIFT (total body K+ normal)

Alkalosis
Insulin administration (especially during DKA treatment)
Beta-2 agonists (albuterol, salbutamol, ritodrine)
Thyrotoxic periodic paralysis (TPP) - common in Asian males
Familial hypokalemic periodic paralysis (KCNJ2/CACNA1A mutations)
Barium poisoning

Clinical Features of Hypokalemia

Severity increases with degree of hypokalemia:

Serum K+	Features
3.0-3.5	Often asymptomatic; minor ECG changes (U waves), mild fatigue
2.5-3.0	Muscle weakness, cramps, constipation, ventricular ectopy
<2.5	Generalized muscle weakness, torsades de pointes, rhabdomyolysis, ascending paralysis
<2.0	Respiratory muscle weakness, potentially fatal arrhythmias

ECG changes in Hypokaemia:

Flattening/inversion of T waves
Prominent U waves (most characteristic - appears after the T wave)
ST depression
Prolonged QU interval
Risk of torsades de pointes (particularly if also taking QT-prolonging drugs)

Other effects:

Renal: Nephrogenic DI (polyuria/polydipsia), metabolic alkalosis, hypokalemic nephropathy
GI: Ileus, constipation
Metabolic: Impaired insulin secretion, altered glucose homeostasis
Hypomagnesemia is commonly concurrent and causes refractory hypokalemia - must replace Mg2+ first

Treatment of Hypokalemia

Severity	Treatment
K+ 3.0-3.5 (mild, asymptomatic)	Dietary K+ increase (bananas, oranges, potatoes); oral KCl 40-100 mEq/day
K+ 2.5-3.0 (moderate)	Oral KCl; if unable to take orally, IV KCl
K+ <2.5 or symptomatic	IV KCl; max infusion rate 10-20 mEq/hr (40 mEq/hr only in severe with continuous cardiac monitoring) - NEVER bolus IV potassium
Concurrent hypomagnesemia	Replace Mg2+ first (IV MgSO4); otherwise K+ replacement will fail

Preferred salt: KCl (potassium chloride) in most patients; potassium citrate/bicarbonate in patients with metabolic acidosis or renal stones

Potassium-sparing diuretics (spironolactone, eplerenone, amiloride, triamterene): Add to thiazide/loop diuretics to prevent ongoing K+ wasting.

National Kidney Foundation Primer, 8th Ed; Comprehensive Clinical Nephrology, 7th Ed

HYPERKALEMIA (K+ > 5.0 mEq/L)

Definition & Risk

Hyperkalemia is uncommon in healthy individuals (< 1% prevalence) due to potent renal excretion mechanisms. Chronic hyperkalemia should always raise suspicion for impaired renal K+ excretion.

Severity classification:

Mild: 5.0-5.9 mEq/L
Moderate: 6.0-6.4 mEq/L
Severe: ≥ 6.5 mEq/L

Causes

1. PSEUDOHYPERKALEMIA (Spurious - no true elevation)

Hemolysis during blood draw (most common cause of elevated K+ on labs!)
Severe leukocytosis (WBC >70,000) or thrombocytosis (platelets >500-1000 × 10⁹/L)
Prolonged tourniquet time, fist clenching
Diagnosis: Plasma K+ is >0.3 mmol/L lower than simultaneous serum K+
Always repeat with atraumatic draw before treating

2. TRANSCELLULAR SHIFT (extracellular shift)

Acidosis (metabolic > respiratory)
Insulin deficiency / DKA (hypertonicity + insulin lack)
Beta-blockade
Digitalis toxicity (inhibits Na-K-ATPase)
Hyperkalemic periodic paralysis (rare)
Massive cell destruction: rhabdomyolysis, tumor lysis syndrome, severe hemolysis, massive blood transfusion, crush injuries, burns

3. INCREASED INTAKE (rarely causes persistent hyperkalemia alone)

IV potassium excess
K+-containing salt substitutes
Blood transfusions

4. DECREASED RENAL EXCRETION (the most common cause of sustained hyperkalemia)

CKD/ESRD (primary cause)
Hypoaldosteronism: Addison's disease, hyporeninemic hypoaldosteronism (type 4 RTA in diabetic nephropathy)
Drugs blocking K+ excretion: ACE inhibitors, ARBs, potassium-sparing diuretics (spironolactone, eplerenone, amiloride), NSAIDs, heparin, trimethoprim-sulfamethoxazole
Obstructive uropathy

ECG Changes in Hyperkalemia (Most Important Feature)

ECG changes are the key to clinical management and represent a medical emergency:

ECG changes in hyperkalemia showing progressive waveform changes with rising potassium levels

Electrocardiographic Changes in Hyperkalemia - Comprehensive Clinical Nephrology, 7th Ed

Serum K+ (mEq/L)	ECG Change
4-5	Normal
5-6	Tall, peaked ("tented") T waves - first sign
6-7	Peaked T waves; PR prolongation
7-8	Flattened P waves, widened QRS, depressed ST
8-9	Absent P waves (atrial standstill), further QRS widening
>9	Sine wave pattern → Ventricular fibrillation → cardiac arrest

The ECG provides the urgency signal for treatment. ECG changes can precede symptoms and do not always correlate linearly with serum K+ levels.

Non-cardiac effects: Generalized muscle weakness, ascending paralysis, and in severe cases, diaphragmatic weakness causing respiratory failure.

Evaluation of Hyperkalemia

Evaluation flowchart for hyperkalemia starting with ECG assessment

Fig. Workup of hyperkalemia - Comprehensive Clinical Nephrology, 7th Ed

Treatment of Hyperkalemia

Treatment has three sequential goals:

Stage 1: Cardiac Membrane Stabilization (FASTEST - acts in minutes)

IV Calcium Gluconate (10 mL of 10% solution over 2-3 min)

Mechanism: Raises action potential threshold, restores normal excitability
Onset: 1-3 minutes; Duration: 30-60 minutes
Does NOT lower K+ - only protects the heart while you lower K+
Caution: Potentiates digoxin toxicity - dilute and infuse slowly over 20-30 min if patient is on digoxin
Repeat if no ECG improvement or if ECG changes recur

Stage 2: Redistribute K+ Into Cells (30-60 min to act)

Drug	Dose	Mechanism	Onset	Duration
Insulin + Dextrose	10 U regular insulin IV + 50 mL D50W (25g glucose)	Activates Na-K-ATPase	10-20 min	4-6 hrs
Nebulized Albuterol	10-20 mg nebulized over 10 min	Beta-2 stimulation → cellular K+ uptake	30 min	2-6 hrs
NaHCO3	150 mEq in 1L D5W infused over hours	Corrects acidosis (adjunct only)	Hours	Several hours

Insulin + glucose is the first-line redistributive treatment
Albuterol and insulin have additive effects; ~20% of ESRD patients are resistant to albuterol alone
Bicarbonate has no role in acute treatment but may help in metabolic acidosis over hours
Follow glucose closely after insulin - hypoglycemia is common; use D10W infusion at 50-75 mL/hr after bolus

Stage 3: Remove K+ From the Body

Method	Notes
Loop diuretics (furosemide)	If renal function allows; promotes kaliuresis
Sodium polystyrene sulfonate (Kayexalate)	Cation exchange resin; onset hours; enteral
Patiromer (newer)	K+-binding resin; well tolerated; oral; chronic use
Sodium zirconium cyclosilicate (ZS-9)	Newer selective K+ exchanger; rapid onset (~1 hr)
Dialysis (hemodialysis)	Fastest and most reliable removal; for severe/refractory or ESRD

Harrison's Principles of Internal Medicine 22E; Comprehensive Clinical Nephrology, 7th Ed

Summary Comparison Table

Feature	Hyponatremia	Hypernatremia	Hypokalemia	Hyperkalemia
Definition	Na+ <136	Na+ >144	K+ <3.5	K+ >5.0
Key mechanism	Water excess or Na+ loss	Water deficit	Losses / shifts / intake	Impaired excretion / shifts
Pathophysiology	Brain cell swelling (↓ osmolality)	Brain cell shrinkage (↑ osmolality)	RMP more negative → hyperpolarization	RMP less negative → depolarization blockade
Main symptoms	Headache, confusion, seizures, coma	Thirst, confusion, seizures, coma	Weakness, cramps, arrhythmias	Weakness, ECG changes, VF/arrest
Key lab	Measure plasma osmolality + urine Na+	Urine osmolality, urine Na+, ADH	Urine K+, Mg2+, pH, aldosterone	ECG, plasma vs serum K+, aldosterone
Most feared complication	Cerebral edema (acute); ODS if overcorrected	Cerebral hemorrhage (bridging vein rupture)	Torsades de pointes, paralysis	Ventricular fibrillation
Rate of correction	Max 8-10 mEq/L per 24 hrs	Max 10-12 mEq/L per 24 hrs	Gradual (IV max 20 mEq/hr)	Urgent if ECG changes
Emergency Rx	3% hypertonic saline (acute + symptomatic)	D5W / 0.45% NS; free water orally	IV KCl (with monitoring)	IV Ca-gluconate → insulin/dextrose → dialysis

Key Mnemonics for MBBS Exams

Causes of SIADH - "SIADH":

S - Surgery / SSRIs
I - Intracranial (meningitis, SAH, stroke)
A - Acute respiratory (TB, pneumonia)
D - Drugs (carbamazepine, cyclophosphamide, morphine)
H - Hormones / Hypothyroid / Hypoadrenalism / Hemorrhage

Causes of Hyperkalemia - "RAID":

R - Renal failure / Redistribution (acidosis)
A - Addison's disease (hypoaldosteronism)
I - Intake excess / Iatrogenic / drugs (ACEi, ARB, K-sparing diuretics)
D - Destruction of cells (rhabdo, tumor lysis, hemolysis)

Hyperkalemia ECG progression (ascending K+):

"TPAQSV" - T peaked → P flattened → QRS widened → Atrial standstill → Sine wave → Ventricular fibrillation

Sources: Goldman-Cecil Medicine International Edition; Harrison's Principles of Internal Medicine 22E (2025); Comprehensive Clinical Nephrology 7th Ed; National Kidney Foundation Primer on Kidney Diseases 8th Ed; Tietz Textbook of Laboratory Medicine 7th Ed; Medical Physiology (Boron & Boulpaep); Brenner & Rector's The Kidney

Please continue writing

Finding Sources

Reading File

Finding Sources

Reading File

Loading Image

Finding Sources

Reading File

I now have all the content needed for a thorough continuation. Here is the detailed continuation:

CONTINUATION: Deeper Clinical Coverage

PART 3: ADVANCED CLINICAL DETAILS - HYPONATREMIA

The Adrogue-Madias Formula (Infusate Effect on Serum Na+)

When treating hyponatremia with any IV fluid, this formula estimates how much each liter of infusate will change the serum Na+:

Change in serum [Na+] per liter of infusate = (Infusate [Na+] - Serum [Na+]) / (TBW + 1)

Infusate	Na+ Content (mEq/L)
3% NaCl (hypertonic saline)	513
0.9% NaCl (normal saline)	154
Ringer's Lactate	130
0.45% NaCl (half normal)	77
D5W (5% dextrose in water)	0 (free water)

Example: Patient with serum Na+ = 115, TBW = 35 L (70 kg man × 0.5 due to illness)

Using 3% NaCl: change per liter = (513 - 115) / (35 + 1) = 398/36 = +11 mEq/L per liter
To raise Na+ by 5 mEq, you need: 5/11 = ~0.45 L = 450 mL of 3% NaCl

Practical point: This formula underestimates the actual rise because it does not account for ongoing free water excretion as ADH is suppressed. Monitor serum Na+ every 2 hours during active correction.

Comprehensive Clinical Nephrology, 7th Ed

Treatment Protocol for Hyponatremia - Step by Step

Acute Symptomatic Hyponatremia (<48 hrs, with seizures/coma)

Bolus 100 mL of 3% NaCl IV over 10 minutes - can repeat ×2 (total up to 300 mL) until seizures stop
Target: raise Na+ by 4-6 mEq/L in first 6 hours (enough to reverse cerebral edema)
Then slow the rate to stay within 8-10 mEq/L per 24 hours
Add furosemide to enhance free water excretion if needed

Chronic Asymptomatic or Mildly Symptomatic Hyponatremia

Treatment Option	Mechanism	Dose	Notes
Fluid restriction	Reduces free water intake	500-800 mL/day	First line for SIADH; cheap, effective
0.9% NaCl	Volume replacement	Guided by deficit	Only for hypovolemic hyponatremia
Demeclocycline	Induces nephrogenic DI (blocks ADH at tubule)	300-600 mg twice daily	Chronic SIADH; risk nephrotoxicity, photosensitivity
Tolvaptan (V2 antagonist, oral)	Aquaresis - free water excretion without Na+ loss	15 mg daily; titrate up	SIADH, CHF, cirrhosis; do NOT use >30 days (hepatotoxicity)
Conivaptan (V1a + V2 antagonist, IV)	Aquaresis	20 mg IV loading, then infusion	Hospital use only; SIADH
Urea	Osmotic diuresis	15-60 g/day orally	Alternative to vaptans; cheap
Salt tablets + fluid restriction	Direct Na+ supplementation	2-3 g salt tablets	Low urine Osm patients

Treating underlying cause is always primary:

CHF: ACE inhibitors, diuretics, optimizing cardiac output
Hypothyroidism: Levothyroxine
Adrenal insufficiency: Glucocorticoids/mineralocorticoids (correct first - giving saline before cortisol can cause dangerous over-correction)
SIADH: Remove offending drugs, treat infection/malignancy

Cerebral Salt Wasting (CSW) vs. SIADH - Critical Distinction

Both cause euvolemic-appearing hyponatremia with elevated urine Na+. Clinically important because their treatments are opposite:

Feature	SIADH	Cerebral Salt Wasting
Setting	Many causes	Primarily subarachnoid hemorrhage, TBI, neurosurgery
Mechanism	Inappropriate ADH → water retention	Brain natriuretic peptide → renal Na+ wasting → volume contraction → secondary ADH
Volume status	Euvolemic (clinically)	Hypovolemic (key difference)
BUN/Creatinine	Low (diluted)	Normal to slightly elevated
Uric acid	Low	Low
Urine Na+	High (>40)	High (>40)
Treatment	FLUID RESTRICTION	IV saline (volume replacement + Na+ replacement)

Treating CSW with fluid restriction (as you would SIADH) will worsen hypovolemia and cause cerebral vasospasm in SAH - potentially catastrophic. Always assess volume status carefully.

Comprehensive Clinical Nephrology, 7th Ed; Bradley & Daroff's Neurology in Clinical Practice

Special Populations: Hyponatremia

Exercise-Associated Hyponatremia (EAH):

Common in marathon runners, military recruits
Caused by excessive hypotonic fluid intake during prolonged exercise
Compounded by non-osmotic ADH release (pain, nausea, stress)
Can be rapidly fatal from cerebral herniation
Treatment: Hypertonic saline (3%) - even in field settings if severe

Post-operative Hyponatremia:

Hypotonic IV fluids + non-osmotic ADH release from pain/stress/nausea
Pre-menopausal women and children at highest risk
Prevention: use isotonic (0.9% NaCl) for routine IV fluid replacement

Beer Potomania / Tea-and-Toast Syndrome:

Extremely low dietary solute intake (malnourished patients, heavy beer drinkers)
Kidneys cannot generate enough urine to excrete free water without solute
Even normal water intake dilutes Na+
Treatment: Increase dietary solutes; fluid restriction

PART 4: ADVANCED CLINICAL DETAILS - HYPERNATREMIA

Diagnostic Algorithm for Hypernatremia

Fig. Diagnostic approach to hypernatremia - Washington Manual of Medical Therapeutics

Interpretation of urine osmolality in hypernatremia:

Urine Osm	Diagnosis
>800 mOsm/L	Normal renal response - extrarenal water loss (GI, insensible, skin), or primary hypodipsia
300-800 mOsm/L	Partial DI, or osmotic diuresis (check 24-hr urine osmoles: if >900 mOsm/day = osmotic diuresis)
<300 mOsm/L + DDAVP response +	Central DI
<300 mOsm/L + DDAVP no response -	Nephrogenic DI

Central DI vs. Nephrogenic DI - Deep Dive

Water Deprivation Test:

Withhold water for 4-18 hours (under supervision)
Measure urine osmolality hourly
When urine Osm plateaus (or weight drops 3-5%), administer DDAVP (10 mcg intranasal)
Measure urine Osm 1-2 hours after DDAVP

Result	Diagnosis
Urine Osm >800 after deprivation alone	Normal (primary polydipsia or reset osmostat)
Urine Osm rises >50% after DDAVP	Central DI
Urine Osm rises <10% after DDAVP	Nephrogenic DI
Intermediate rise (10-50%)	Partial central or nephrogenic DI

Treatment of Nephrogenic DI:

Drug	Mechanism
Thiazide diuretics (paradoxical)	Volume contraction → proximal Na+/water reabsorption → less water delivered distally
Low Na+ / low protein diet	Reduces urine solute load, less obligate water loss
NSAIDs (indomethacin)	Reduce prostaglandin-mediated inhibition of ADH in tubule
Amiloride	Specifically for lithium-induced NDI - blocks lithium entry into collecting duct cells
DDAVP	Useless in complete NDI; may help partial NDI

Hypernatremia Treatment - Full Protocol

Correction Rate: Max 0.5 mEq/L/hr (or 10-12 mEq/L per day) for chronic hypernatremia. For acute sodium loading, up to 1 mEq/L/hr may be safer.

Step-by-step approach:

Hemodynamic instability first: Give 0.9% NaCl to restore circulating volume (even though it contains Na+, the priority is perfusion)
Calculate free water deficit: TBW × [(actual Na+ / 140) - 1]
Add ongoing losses (insensible, urine, GI) to daily replacement needs
Choose fluid:
- D5W: delivers pure free water (used when Na+ balance is positive or normal)
- 0.45% NaCl: half isotonic; used when some Na+ replacement also needed
- Oral/enteral water: safest and easiest to titrate in conscious patients
Monitor serum Na+ every 4-6 hours during active correction
Treat the cause: DDAVP for central DI; thiazide + low-solute diet for nephrogenic DI; stop offending drugs

Total Body Water Fractions by Population:

Population	TBW Fraction
Children + adult men	0.6 × weight (kg)
Adult women	0.5 × weight (kg)
Elderly men	0.5 × weight (kg)
Elderly women	0.45 × weight (kg)

Washington Manual of Medical Therapeutics; National Kidney Foundation Primer, 8th Ed

PART 5: ADVANCED CLINICAL DETAILS - HYPOKALEMIA

Renal vs. Extra-renal Loss - Diagnostic Approach

Transtubular Potassium Gradient (TTKG):

TTKG = (Urine K+ / Plasma K+) / (Urine Osm / Plasma Osm)

TTKG	Interpretation
>4 (in hypokalemia)	Renal K+ wasting (inappropriate renal losses)
<2 (in hypokalemia)	Extra-renal losses (GI, skin, inadequate intake)

Simpler rule - Urine K+:

Random urine K+ >20-25 mEq/L = renal losses
Random urine K+ <20 mEq/L = extra-renal losses

Causes of Hypokalemia with Hypertension

This is a classic MBBS exam scenario:

Condition	Aldosterone	Renin	Other Features
Primary hyperaldosteronism (Conn's)	High	Low	Most common cause; adrenal adenoma or hyperplasia; MRI adrenals
Secondary hyperaldosteronism (RAS, RVH, renin-secreting tumor)	High	High	Renovascular hypertension
Cushing's syndrome (cortisol excess)	High	Low	Central obesity, striae, buffalo hump; cortisol has mineralocorticoid activity
Liddle syndrome (gain-of-function ENaC)	Low	Low	Genetic; pseudohyperaldosteronism; treat with amiloride
Apparent mineralocorticoid excess (11β-HSD2 deficiency)	Low	Low	Licorice ingestion (glycyrrhizin) inhibits 11β-HSD2; carbenoxolone
Glucocorticoid-remediable aldosteronism	High	Low	Familial; aldosterone production driven by ACTH; responds to dexamethasone

Hypokalemic Periodic Paralysis - Full Picture

A clinically tested topic in MBBS:

Types:

Type	Gene Mutation	Trigger	K+ during attack	Notes
Familial HypoPP Type 1	CACNA1A (L-type Ca channel)	Carbohydrate meal, rest after exercise, cold	Very low (<2)	Autosomal dominant; treat with K+ supplementation
Familial HypoPP Type 2	SCN4A (skeletal Na channel)	Same as above	Very low
Thyrotoxic PP (TPP)	Kir2.6 / KCNJ2	Carbohydrate, stress, exertion	Very low	Asian males (90%), non-inherited; treat hyperthyroidism + propranolol (3 mg/kg); K+ replacement cautiously
Hyperkalemic PP	SCN4A (gain-of-function)	Fasting, rest after exercise, cold	High/normal	Shorter attacks; Mexiletine for prophylaxis

Clinical features of attack:

Acute onset of proximal > distal flaccid weakness, especially lower limbs
Usually begins in early morning after large carbohydrate meal
Bulbar, ocular, and respiratory muscles usually spared
ECG shows hypokalemia changes: flat/inverted T waves, prominent U waves, prolonged QU interval
Resolves spontaneously or with K+ replacement

Caution in TPP: Total body K+ is NOT depleted - K+ has merely shifted intracellularly. Overzealous replacement causes rebound hyperkalemia after thyroid treatment. Give IV K+ sparingly (10 mEq boluses, not rapid large doses).

Rosen's Emergency Medicine; Harrison's Principles of Internal Medicine 22E

Magnesium and Potassium: The Critical Link

Hypomagnesemia is one of the most commonly missed causes of refractory hypokalemia. It must always be checked and corrected before attempting K+ repletion.

Mechanism: Mg2+ is required for Na-K-ATPase function and for keeping K+ inside cells. It also suppresses the ROMK channel (responsible for tubular K+ secretion) in the thick ascending limb. Without Mg2+, urinary K+ wasting continues regardless of how much K+ you give.

Rule: If a patient's K+ fails to correct despite IV replacement, check and replace Mg2+ (IV MgSO4).

PART 6: ADVANCED CLINICAL DETAILS - HYPERKALEMIA

Drug-Induced Hyperkalemia - Comprehensive List

Understanding which drugs raise K+ is essential clinically:

Drug Class	Mechanism
ACE inhibitors / ARBs	Block angiotensin II → reduce aldosterone → reduce tubular K+ secretion
Potassium-sparing diuretics (spironolactone, eplerenone)	Block aldosterone receptor → same as above
Amiloride, triamterene	Block ENaC directly → reduce K+ secretion
NSAIDs	Reduce prostaglandin → reduce renin → reduce aldosterone
Heparin	Directly inhibits aldosterone synthesis
Trimethoprim (high-dose)	Blocks ENaC (like amiloride)
Beta-blockers	Block beta-2 → prevent cellular K+ uptake
Digoxin (toxic levels)	Inhibits Na-K-ATPase → K+ leaks out of cells
Succinylcholine	Triggers massive K+ efflux from muscle (dangerous in burns, crush, denervation, prolonged immobility)
Cyclosporine / Tacrolimus	Reduce aldosterone activity
Penicillin G (high-dose potassium salt)	Direct K+ load

New Oral Potassium Binders

These agents have largely replaced the old Kayexalate for chronic hyperkalemia management:

Agent	Mechanism	Onset	Key Use
Patiromer (Veltassa)	Ca2+-sorbitol cation exchanger; binds K+ in colon	6-7 hours	Chronic hyperkalemia in CKD, HF; cannot use in emergencies
Sodium Zirconium Cyclosilicate (Lokelma/SZC)	Selective ion exchanger; binds K+ in gut (all segments)	~1 hour (fastest oral agent)	Both acute and chronic settings; reduces K+ >6.0 to <5.5 in median 4 hours
Sodium Polystyrene Sulfonate (Kayexalate)	Exchanges Na+ for K+ in colon	Unpredictable	No longer recommended for emergency use due to risk of colonic necrosis

Barash Clinical Anesthesia, 9th Ed; National Kidney Foundation Primer, 8th Ed

Hyperkalemia in Special Settings

Diabetic Ketoacidosis (DKA) and Potassium:

On presentation: serum K+ is often NORMAL or HIGH despite massive total body K+ deficit
This is because: insulin deficiency + hypertonicity shift K+ from ICF to ECF
As you treat DKA with insulin + fluids: K+ rapidly drops → can cause dangerous hypokalemia
Rule: Start K+ replacement when serum K+ falls below 5.0 mEq/L, and MUST replace before insulin if K+ < 3.5

Tumor Lysis Syndrome (TLS):

Massive cell destruction (chemotherapy for lymphoma, leukemia, bulky tumors)
Releases K+, phosphate, uric acid, and nucleic acids
Classic biochemical triad: hyperkalemia + hyperphosphatemia + hypocalcemia + hyperuricemia
Can lead to fatal arrhythmia from hyperkalemia
Prevention: aggressive hydration + allopurinol or rasburicase before chemotherapy

Rhabdomyolysis:

Massive muscle breakdown → K+ release + myoglobin → AKI (which worsens hyperkalemia further)
Other electrolytes: hyperphosphatemia, hypocalcemia (early), hypercalcemia (late recovery)
Treatment: aggressive IV hydration (target urine output >200-300 mL/hr), urinary alkalinization

Succinylcholine-Induced Hyperkalemia:

In normal patients, succinylcholine raises K+ by only ~0.5-1.0 mEq/L (acceptable)
In denervated muscle (burns, crush injury, spinal cord injury, prolonged ICU stay, stroke): massive K+ efflux can cause K+ to rise by 5-10 mEq/L → cardiac arrest
Contraindicated in these conditions; use non-depolarizing NMBAs instead

PART 7: PHYSIOLOGY DEEP DIVE - Why These Electrolytes Matter

Sodium and Osmolality - The Core Concept

Sodium is the main determinant of plasma osmolality:

Plasma Osmolality = 2 × Na+ + (Glucose/18) + (BUN/2.8)

Normal = 280-295 mOsm/kg. Sodium accounts for ~90% of ECF osmolality.

Osmoreceptors in the hypothalamus (OVLT neurons) detect a rise in osmolality as small as 1-2 mOsm/kg and:

Trigger ADH (vasopressin) release from posterior pituitary → water retention in collecting duct (V2 receptors → aquaporin-2 insertion)
Stimulate thirst → water intake

Baroreceptors in the carotid sinus and aorta detect volume changes and:

Trigger renin-angiotensin-aldosterone system → Na+ (and water) retention
Provide a non-osmotic stimulus for ADH release (takes priority over osmolality in severe volume depletion)

Potassium and the Resting Membrane Potential - Why K+ Changes Are Dangerous

The resting membrane potential (RMP) of most cells is approximately -90 mV and is primarily determined by the ratio of intracellular to extracellular K+:

RMP ≈ -61 × log([K+]i / [K+]e) (Nernst equation)

In Hypokalemia (low extracellular K+):

The K+ gradient becomes steeper → RMP becomes more negative (hyperpolarized), e.g., -100 mV
Cell is harder to excite - threshold is harder to reach
Paradoxically, this causes: reduced excitability of skeletal muscle (weakness), but also increased excitability of cardiac conduction tissue and pacemaker cells
Clinical result: U waves on ECG, torsades de pointes, ventricular fibrillation

In Hyperkalemia (high extracellular K+):

K+ gradient narrows → RMP becomes less negative (depolarized), e.g., -70 mV
Cell is initially more excitable, then undergoes depolarization blockade (Na+ channels are inactivated)
Clinical result: peaked T waves → widened QRS → loss of P waves → sine wave → VF
Skeletal muscle: weakness and flaccid paralysis (depolarization blockade)

PART 8: EXAM-FOCUSED HIGH-YIELD POINTS

Most Commonly Tested Exam Facts

Hyponatremia:

Most common electrolyte disorder in hospitalized patients
First step in workup: measure plasma osmolality
Most common cause of SIADH: small cell lung cancer (ectopic ADH), and drugs (SSRIs)
Rate of correction: never exceed 8-10 mEq/L in 24 hours (risk ODS/CPM)
Overcorrection treatment: give free water (D5W) or DDAVP to re-lower Na+ if correction was too fast

Hypernatremia:

Always reflects free water deficit (not sodium excess, usually)
Always accompanied by hypertonicity
Symptoms = brain cell shrinkage (opposite of hyponatremia)
Key formula: Free water deficit = TBW × [(Na+ / 140) - 1]
Must correct hemodynamic instability with 0.9% NaCl FIRST, then address water deficit

Hypokalemia:

Most common cause: loop and thiazide diuretics
Always check and replace Mg2+ - hypomagnesemia causes refractory hypokalemia
Never give IV K+ as bolus - max infusion 10-20 mEq/hr
Danger: K+ < 2.5 → torsades de pointes, rhabdomyolysis
DKA treatment: watch K+ fall as insulin drives it intracellularly

Hyperkalemia:

Most common spurious cause: hemolysis during blood draw
Most common true cause: CKD / impaired renal excretion
ECG is your urgency guide - presence of ECG changes = medical emergency
First treatment: IV Calcium gluconate (cardiac protection, does not lower K+)
Second: Insulin + dextrose (shifts K+ in, fastest acting)
Third: Remove K+ - dialysis is the most reliable and definitive

Quick Comparison: ECG Changes

Disorder	ECG Findings
Hypokalemia	Flattened/inverted T waves, prominent U waves, ST depression, prolonged QU interval
Hyperkalemia	Tall peaked T waves → PR prolongation → wide QRS → absent P → sine wave → VF
Hyponatremia	Non-specific (rarely causes primary ECG changes; effects are neurological)
Hypernatremia	Non-specific; may see tachycardia from volume depletion

One-Line High-Yield Associations for MCQs

Clinical Clue	Diagnosis
SAH + hyponatremia + hypovolemia	Cerebral salt wasting
SCLC + hyponatremia + no edema + urine Na >40	SIADH
Hypertension + hypokalemia + low renin + high aldo	Primary hyperaldosteronism (Conn's)
Asian male + hypokalemia + acute weakness + high T4	Thyrotoxic periodic paralysis
Lithium use + polyuria + hypernatremia + no DDAVP response	Nephrogenic DI
DKA treatment → falling K+	Insulin driving K+ intracellularly - replace K+
Hemolyzed sample + "high K+"	Pseudohyperkalemia - repeat test
Rapid correction of chronic hyponatremia → quadriplegia	Osmotic demyelination syndrome (CPM)
Burns/crush injury patient + succinylcholine → cardiac arrest	Hyperkalemia from succinylcholine
Chemotherapy + high K+, high PO4, low Ca2+	Tumor lysis syndrome
Licorice excess + hypertension + hypokalemia + low renin + low aldo	Apparent mineralocorticoid excess
Marathon runner drinking excessive water → hyponatremia	Exercise-associated hyponatremia

Sources used throughout this guide:

Goldman-Cecil Medicine International Edition, 2-Volume Set
Harrison's Principles of Internal Medicine 22E (2025)
Comprehensive Clinical Nephrology, 7th Edition
National Kidney Foundation Primer on Kidney Diseases, 8th Edition
Tietz Textbook of Laboratory Medicine, 7th Edition
Medical Physiology (Boron & Boulpaep)
Rosen's Emergency Medicine
Washington Manual of Medical Therapeutics
Brenner & Rector's The Kidney, 2-Volume Set
Barash, Cullen & Stoelting's Clinical Anesthesia, 9th Edition
Bradley & Daroff's Neurology in Clinical Practice

This is a shared conversation. Sign in to Orris to start your own chat.